Abstract: The importance of trophic factors, such as nerve growth factor (NGF), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (BDNF) during the perinatal period, is now emerging. Through their functional activities of neurogenesis and angiogenesis, they play a key role in the final maturation of the nervous and vascular systems. The present study aims to: (i) evaluate the NGF and VEGF levels obtained at parturition from the mare, foal and umbilical cord vein plasma, as well as in amniotic fluid; (ii) evaluate NGF and VEGF content in the plasma of healthy foals during the first 72 h of life (T0, T24 and T72); (iii) evaluate NGF and VEGF levels at parturition in relation to the selected mares’ and foals’ clinical parameters; (iv) evaluate the relationship between the two trophic factors and the thyroid hormone levels (TT3 and TT4) in the first 72 h of life; (v) assess mRNA expression of NGF, VEGF and BDNF and their cell surface receptors in the placenta. Fourteen Standardbred healthy foals born from mares with normal pregnancies and parturitions were included in the study. The dosage of NGF and VEGF levels was performed using commercial ELISA kits, whereas NGF, VEGF and BDNF placental gene expression was performed using semi-quantitative real-time PCR. In foal plasma, both NGF and VEGF levels decreased significantly over time, from T0 to T24 (p = 0.0066 for NGF; p < 0.0001 for VEGF) and from T0 to T72 (p = 0.0179 for NGF; p = 0.0016 for VEGF). In foal serum, TT3 levels increased significantly over time from T0 to T24 (p = 0.0058) and from T0 to T72 (p = 0.0013), whereas TT4 levels decreased significantly over time from T0 to T24 (p = 0.0201) and from T0 to T72 (p < 0.0001). A positive correlation was found in the levels of NGF and VEGF in foal plasma at each time point (p = 0.0115; r = 0.2862). A positive correlation was found between NGF levels in the foal plasma at T0 and lactate (p = 0.0359; r = 0.5634) as well as between VEGF levels in the foal plasma at T0 and creatine kinase (p = 0.0459; r = 0.5407). VEGF was expressed in all fetal membranes, whereas NGF and its receptors were not expressed in the amnion. The close relationship between the two trophic factors in foal plasma over time and their fine expression in placental tissues appear to be key regulators of fetal development and adaptation to extra-uterine life.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research article focuses on assessing the presence and role of trophic factors (specifically nerve growth factor (NGF) and vascular endothelial growth factor (VEGF)) in foals during the perinatal period. It highlights their correlation with developmental processes and adaptation to extra-uterine life.
Objective and Methodology of the Study
The study aims to quantify the levels of trophic factors NGF and VEGF at parturition in the mare, foal, umbilical cord vein plasma, amniotic fluid, and evaluate their progression in foal plasma during the first 72 hours of life.
It also seeks to understand the correlation of these growth factors with selected clinical parameters and thyroid hormone levels in mares and foals during parturition.
The expression of NGF, VEGF, and another factor, brain-derived neurotropic factor (BDNF), and their cell surface receptors in the placenta was assessed.
The subjects of this study were 14 healthy foals born from mares with normal pregnancies and parturitions.
Commercial ELISA kits were used to measure NGF and VEGF levels, while semi-quantitative real-time PCR was used to assay the gene expression in the placenta.
Key Findings of the Study
The study found that both NGF and VEGF levels in the foal’s plasma descended significantly in the first 72 hours after birth.
Contrarily, the TT3 hormone levels elevated while TT4 levels fell in foal serum during the same timeframe.
The study observed a positive correlation between NGF and VEGF levels in the foal plasma.
Additionally, there were positive correlations between NGF levels in foal plasma and lactate and between VEGF levels in the foal plasma and creatine kinase.
VEGF was found to be expressed in all examined fetal membranes, while NGF and its receptors had no expression in the amnion.
In summary, a tight relationship between NGF and VEGF in foal plasma over time and their distinct expression in placental tissues appear crucial to the developmental processes and adaptation to extra-uterine life.
Conclusion
The study offers valuable insights into the roles of trophic factors like NGF and VEGF in the development and adaptation stages of a foal’s life during the perinatal period.
Understanding these mechanisms may have important implications for maintaining the health and vitality of newborn foals and further contribute to advancing veterinary medicine and equine neonatal care.
Cite This Article
APA
Ellero N, Lanci A, Baldassarro VA, Alastra G, Mariella J, Cescatti M, Giardino L, Castagnetti C.
(2022).
Study on NGF and VEGF during the Equine Perinatal Period-Part 1: Healthy Foals Born from Normal Pregnancy and Parturition.
Vet Sci, 9(9), 451.
https://doi.org/10.3390/vetsci9090451
Frade JM, Rodríguez-Tébar A, Barde YA. Induction of cell death by endogenous nerve growth factor through its p75 receptor.. Nature 1996 Sep 12;383(6596):166-8.
Calzà L, Giardino L, Aloe L. NGF content and expression in the rat pituitary gland and regulation by thyroid hormone.. Brain Res Mol Brain Res 1997 Nov;51(1-2):60-8.
Gostynska N, Pannella M, Rocco ML, Giardino L, Aloe L, Calzà L. The pleiotropic molecule NGF regulates the in vitro properties of fibroblasts, keratinocytes, and endothelial cells: implications for wound healing.. Am J Physiol Cell Physiol 2020 Feb 1;318(2):C360-C371.
Pius-Sadowska E, Machaliński B. Pleiotropic activity of nerve growth factor in regulating cardiac functions and counteracting pathogenesis.. ESC Heart Fail 2021 Apr;8(2):974-987.
Amagai Y, Sato H, Ishizaka S, Matsuda K, Aurich C, Tanaka A, Matsuda H. Cloning and Expression of Equine β-Nerve Growth Factor. J. Equine Vet. Sci. 2016;45:28–31.
Charnock-Jones DS, Kaufmann P, Mayhew TM. Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation.. Placenta 2004 Feb-Mar;25(2-3):103-13.
Li Y, Zhang F, Nagai N, Tang Z, Zhang S, Scotney P, Lennartsson J, Zhu C, Qu Y, Fang C, Hua J, Matsuo O, Fong GH, Ding H, Cao Y, Becker KG, Nash A, Heldin CH, Li X. VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats.. J Clin Invest 2008 Mar;118(3):913-23.
Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo.. Proc Natl Acad Sci U S A 2002 Sep 3;99(18):11946-50.
Sawicka-Gutaj N, Zawalna N, Gut P, Ruchała M. Relationship between thyroid hormones and central nervous system metabolism in physiological and pathological conditions.. Pharmacol Rep 2022 Oct;74(5):847-858.
Calza L, Fernandez M, Giuliani A, Aloe L, Giardino L. Thyroid hormone activates oligodendrocyte precursors and increases a myelin-forming protein and NGF content in the spinal cord during experimental allergic encephalomyelitis.. Proc Natl Acad Sci U S A 2002 Mar 5;99(5):3258-63.
Malamitsi-Puchner A, Nikolaou KE, Economou E, Boutsikou M, Boutsikou T, Kyriakakou M, Puchner KP, Hassiakos D. Intrauterine growth restriction and circulating neurotrophin levels at term.. Early Hum Dev 2007 Jul;83(7):465-9.
Hogan KA, Ambler CA, Chapman DL, Bautch VL. The neural tube patterns vessels developmentally using the VEGF signaling pathway.. Development 2004 Apr;131(7):1503-13.
Schwarz Q, Gu C, Fujisawa H, Sabelko K, Gertsenstein M, Nagy A, Taniguchi M, Kolodkin AL, Ginty DD, Shima DT, Ruhrberg C. Vascular endothelial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerve.. Genes Dev 2004 Nov 15;18(22):2822-34.
Aisa MC, Barbati A, Cappuccini B, De Rosa F, Gerli S, Clerici G, Kaptilnyy VA, Ishenko AI, Di Renzo GC. Urinary Nerve Growth Factor in full-term, preterm and intra uterine growth restriction neonates: Association with brain growth at 30-40 days of postnatal period and with neuro-development outcome at two years. A pilot study.. Neurosci Lett 2021 Jan 10;741:135459.
Dhobale M, Mehendale S, Pisal H, Nimbargi V, Joshi S. Reduced maternal and cord nerve growth factor levels in preterm deliveries.. Int J Dev Neurosci 2012 Apr;30(2):99-103.
Sabour S. Prediction of preterm delivery using levels of VEGF and leptin in amniotic fluid from the second trimester: prediction rules.. Arch Gynecol Obstet 2015 Apr;291(4):719.
Chiba A., Aoki T., Itoh M., Yamagishi N., Shibano K.. Hematological and Blood Biochemical Characteristics of Newborn Heavy Draft Foals After Dystocia. J. Equine Vet. Sci. 2017;50:69–75.
Walker P, Weil ML, Weichsel ME Jr, Fisher DA. Effect of thyroxine on nerve growth factor concentration in neonatal mouse brain.. Life Sci 1981 Apr 13-20;28(15-16):1777-87.
Figueiredo BC, Almazan G, Ma Y, Tetzlaff W, Miller FD, Cuello AC. Gene expression in the developing cerebellum during perinatal hypo- and hyperthyroidism.. Brain Res Mol Brain Res 1993 Mar;17(3-4):258-68.
Fujita K, Tatsumi K, Kondoh E, Chigusa Y, Mogami H, Fujii T, Yura S, Kakui K, Konishi I. Differential expression and the anti-apoptotic effect of human placental neurotrophins and their receptors.. Placenta 2011 Oct;32(10):737-44.
Frank P, Barrientos G, Tirado-González I, Cohen M, Moschansky P, Peters EM, Klapp BF, Rose M, Tometten M, Blois SM. Balanced levels of nerve growth factor are required for normal pregnancy progression.. Reproduction 2014 Aug;148(2):179-89.
Wessels JM, Wu L, Leyland NA, Wang H, Foster WG. The brain-uterus connection: brain derived neurotrophic factor (BDNF) and its receptor (Ntrk2) are conserved in the mammalian uterus.. PLoS One 2014;9(4):e94036.
Nakamura K, Martin KC, Jackson JK, Beppu K, Woo CW, Thiele CJ. Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells.. Cancer Res 2006 Apr 15;66(8):4249-55.
Wang LH, Paden AJ, Johnson EM Jr. Mixed-lineage kinase inhibitors require the activation of Trk receptors to maintain long-term neuronal trophism and survival.. J Pharmacol Exp Ther 2005 Mar;312(3):1007-19.
Tervonen TA, Ajamian F, De Wit J, Verhaagen J, Castrén E, Castrén M. Overexpression of a truncated TrkB isoform increases the proliferation of neural progenitors.. Eur J Neurosci 2006 Sep;24(5):1277-85.
Garcés MF, Sanchez E, Torres-Sierra AL, Ruíz-Parra AI, Angel-Müller E, Alzate JP, Sánchez ÁY, Gomez MA, Romero XC, Castañeda ZE, Sanchez-Rebordelo E, Diéguez C, Nogueiras R, Caminos JE. Brain-derived neurotrophic factor is expressed in rat and human placenta and its serum levels are similarly regulated throughout pregnancy in both species.. Clin Endocrinol (Oxf) 2014 Jul;81(1):141-51.
Daneshmand SS, Cheung CY, Brace RA. Regulation of amniotic fluid volume by intramembranous absorption in sheep: role of passive permeability and vascular endothelial growth factor.. Am J Obstet Gynecol 2003 Mar;188(3):786-93.